Key facts
- This page summarizes Jasbir Seehra's Form 4 filing for Keros Therapeutics, Inc. (KROS).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 06 Apr 2026, 16:15.
Jasbir Seehra - 02 Apr 2026 Form 4 Insider Report for Keros Therapeutics, Inc. (KROS)
- Reporting relationship
- CHIEF EXECUTIVE OFFICER, Director
- Issuer ticker
- KROS
- Reported as of
- 02 Apr 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Apr 2026, 16:15:08 UTC
- Prior SEC filing
- 26 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jasbir Seehra
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jasbir Seehra filed Form 4 for Keros Therapeutics, Inc. (KROS) on 06 Apr 2026.
Change
- Previous filing in this sequence was filed on 26 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001732369
Primary reporting owner
Seehra Jasbir
- Relationship
- CHIEF EXECUTIVE OFFICER, Director
- Address
- C/O KEROS THERAPEUTICS, INC., 1050 WALTHAM STREET, SUITE 302, LEXINGTON
- Signature
- /s/ Jasbir Seehra
- Signature date
- 06 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KROS
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +55,000
- Change %
- +14%
- Price
- $0.3000*
- Shares after
- 440,708
- Date
- 02 Apr 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KROS
transaction
Derivative
Employee Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -55,000
- Change %
- -22%
- Price
- $0.000000*
- Shares after
- 197,444
- Date
- 02 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 55,000
- Exercise price
- $0.3000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Immediately exercisable.